CV prognosis good at six months after hospitalization for MIS-C

(HealthDay)—Children with multisystem inflammatory syndrome in children (MIS-C) treated with immunomodulators have favorable outcomes at six months, with normalization of left ventricular (LV) systolic function and resolution of coronary abnormalities, according to a study published online July 29 in Pediatrics. Christine A. Capone, M.D., M.P.H., from the Cohen Children’s Medical…